Guillermo Lopez Campos

2 weeks ago | biorxiv.org | Mary Mccabe |Helen Groves |Emma Campbell |Guillermo Lopez Campos

AbstractRespiratory syncytial virus (RSV) disease burden is greatest between six weeks and 6 months of life, with young age the most common risk factor among hospitalised children. A robust innate immune response in the airway epithelium is crucial for mitigating RSV-associated disease, but early-life immune responses to infection remain largely unexplored.